Raghuram Anjali, Singh Aspinder, Chang Daniel K, Nunez Mervin, Reece Edward M, Schultz Brent E
Baylor College of Medicine, Houston, Texas.
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.
Semin Plast Surg. 2019 Aug;33(3):167-172. doi: 10.1055/s-0039-1693131. Epub 2019 Aug 2.
With the rapid rise of personalized genomic sequencing and clustered regularly interspaced short palindromic repeat (CRISPR) technology, previous gaps in gene therapy are beginning to be bridged, paving the way for increasing clinical applicability. This article aims to provide an overview of the fundamentals of gene therapy and discuss future potential interventions relevant to plastic surgeons. These interventions include enhancing tissue regeneration and healing, as well as modifying disease processes in congenital anomalies. Though clinical applications are still on the horizon, a deeper understanding of these new advances will help plastic surgeons understand the current landscape of gene therapy and stay abreast of future opportunities.
随着个性化基因组测序和规律成簇间隔短回文重复序列(CRISPR)技术的迅速兴起,基因治疗以前存在的差距开始得到弥合,为提高临床适用性铺平了道路。本文旨在概述基因治疗的基本原理,并讨论与整形外科医生相关的未来潜在干预措施。这些干预措施包括促进组织再生和愈合,以及改变先天性异常中的疾病进程。尽管临床应用仍有待实现,但对这些新进展的更深入理解将有助于整形外科医生了解基因治疗的当前形势,并跟上未来的机遇。